8th Oct 2007 15:00
Smith & Nephew Plc08 October 2007 FOR IMMEDIATE RELEASE Contact: Sidonie Myers Head of Communication Smith & Nephew Advanced Wound Management +44 (0) 1482 673246 [email protected] Smith & Nephew announces International launch of New ALLEVYN Ag antimicrobialdressing range HULL, UK Oct 8 2007 - Smith & Nephew's (LSE: SN; NYSE:SNN) Advanced WoundManagement division, announced today that it is launching a new range of ALLEVYNdressings, ALLEVYN Ag, that combine the superior fluid handling of ALLEVYN withthe antimicrobial protection of silver. The new ALLEVYN Ag range of dressings, available in both adhesive and nonadhesive variants have the addition of a broad spectrum, sustained releasesilver. This combined with the existing benefits of ALLEVYN helps to deliverthe optimal moist wound environment for the promotion of faster healing. "The ALLEVYN Ag dressing is very easy to use and we are getting somegreat outcomes. One patient that had an open surgical wound remarked that thedressing was a "miracle" and very comfortable," said Paula Kotz as, BSN, RN, C,CWOCN, ET Consultant Services Inc., Asheville, NC. "The addition of the ALLEVYN Ag range to the brand will help strengthen ourposition further in 2008 as the leading global brand within the foam dressingsmarket," said Joe Woody, President, Smith & Nephew Advanced Wound Management. "The new products further build on the major improvements made to ALLEVYN in 2006that have been extremely well received by our customers. The ALLEVYN Ag rangewill offer even more benefits to our customers and will continue to improve thequality of life of their patients." ALLEVYN helps to facilitate healing by reducing the risk of maceration andmaintaining an optimal moist wound environment. ALLEVYN offers the clinician aclinically proven range of dressings that are cost effective both for theclinician and the buyer. With the addition of ALLEVYN Ag to the range, ALLEVYNis able to provide an all in one solution when bacterial colonisation is anissue. Smith & Nephew Advanced Wound Management is headquartered in Hull, UK where ithas its main manufacturing facility. The organisation also has a manufacturingcentre in the US in Largo, Florida. • Trademark of Smith & Nephew Notes for Editors About Us Smith & Nephew Advanced Wound Management, with headquarters in the UnitedKingdom, employs more than 3,100 people around the world. The organisation hasmanufacturing centres in the United Kingdom and Largo, FL. Smith & Nephew is a global medical technology business, specialising inOrthopaedic Reconstruction, Orthopaedic Trauma and Clinical Therapies, Endoscopy and Advanced WoundManagement products. Smith & Nephew is a global leader in arthroscopy and advanced wound managementand is one of the leading global orthopaedics companies. Smith & Nephew is dedicated to helping improve people's lives. The Companyprides itself on the strength of its relationships with its surgeons andprofessional healthcare customers, with whom its name is synonymous with highstandards of performance, innovation and trust. The Company has 9,600 employeesand operates in 31 countries around the world. Annual sales in 2006 were nearly$2.8 billion. Forward-Looking Statements This press release contains certain "forward-looking statements" within themeaning of the US Private Securities Litigation Reform Act of 1995. In particular, statements regardingexpected revenue growth and trading margins discussed under "Outlook" areforward-looking statements as are discussions of our product pipeline. Thesestatements, as well as the phrases "aim", "plan", "intend", "anticipate","well-placed","believe", "estimate", "expect", "target", "consider" and similarexpressions, are generally intended to identify forward-looking statements. Suchforward-looking statements involve known and unknown risks, uncertainties andother important factors (including, but not limited to, the outcome oflitigation, claims and regulatory approvals) that could cause the actualresults, performance or achievements of Smith & Nephew, or industry results, todiffer materially from any future results, performance or achievements expressedor implied by such forward-looking statements. Please refer to the documentsthat Smith & Nephew has filed with the U.S. Securities and Exchange Commissionunder the U.S. Securities Exchange Act of 1934, as amended, including Smith &Nephew's most recent annual report on Form 20F, for a discussion of certain ofthese factors. All forward-looking statements in this press release are based on informationavailable to Smith & Nephew as of the date hereof. All written or oralforward-looking statements attributable to Smith & Nephew or any person actingon behalf of Smith & Nephew are expressly qualified in their entirety by theforegoing. Smith & Nephew does not undertake any obligation to update or reviseany forward-looking statement contained herein to reflect any change in Smith &Nephew's expectation with regard thereto or any change in events, conditions orcircumstances on which any such statement is based. Trademark of Smith & Nephew. Certain marks registered US Patent and TrademarkOffice. This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
Smith & Nephew